Phesi Receives Frost Sullivan's Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform
- Written by PR Newswire
Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest standards of data integrity and patient-centricity
SAN ANTONIO, Sept. 4, 2024 /PRNewswire/ -- Frost & Sullivan has recognized Phesi with the 2024 Global Enabling Technology...
